Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PhaseBio Pharmaceuticals Inc | Chief Financial Officer | Common Stock | 65.8K | May 20, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PHASQ | PhaseBio Pharmaceuticals Inc | May 20, 2022 | 1 | $4.11K | 4 | May 24, 2022 | Chief Financial Officer |
PHASQ | PhaseBio Pharmaceuticals Inc | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | Chief Financial Officer |
PHASQ | PhaseBio Pharmaceuticals Inc | Nov 19, 2021 | 1 | $4.05K | 4 | Nov 23, 2021 | Chief Financial Officer |
PHASQ | PhaseBio Pharmaceuticals Inc | Nov 3, 2021 | 2 | $0 | 4 | Nov 3, 2021 | Chief Financial Officer |
PHASQ | PhaseBio Pharmaceuticals Inc | Aug 3, 2021 | 2 | $12.6K | 4/A | Sep 3, 2021 | Chief Financial Officer |
PHASQ | PhaseBio Pharmaceuticals Inc | May 20, 2021 | 1 | $3.97K | 4 | May 24, 2021 | Chief Financial Officer |